Search Results - "Karlberg, Mia"

Image analysis-derived metrics of histomorphological complexity predicts prognosis and treatment response in stage II-III colon cancer by Mezheyeuski, Artur, Hrynchyk, Ina, Karlberg, Mia, Portyanko, Anna, Egevad, Lars, Ragnhammar, Peter, Edler, David, Glimelius, Bengt, Östman, Arne

“…The complexity of tumor histomorphology reflects underlying tumor biology impacting on natural course and response to treatment. This study presents a method…”
Get full text

Persistent prevention of oxaliplatin-induced peripheral neuropathy using calmangafodipir (PledOx ® ): a placebo-controlled randomised phase II study (PLIANT) by Glimelius, Bengt, Manojlovic, Nebojsa, Pfeiffer, Per, Mosidze, Baadur, Kurteva, Galina, Karlberg, Mia, Mahalingam, Devalingam, Buhl Jensen, Peter, Kowalski, Jan, Bengtson, Marie, Nittve, Malin, Näsström, Jacques

“…Oxaliplatin causes disabling acute and chronic peripheral neuropathy. We explored the preventive effects of calmangafodipir, mimicking the mitochondrial enzyme…”
Get more information

Prognostic Factors in Colorectal Cancer : Studies of Thymidylate Synthase Expression, Mismatch Repair Protein Expression, Tumor Budding and t-Cell Infiltration by Karlberg, Mia

“…Colorectal cancer (CRC) is a major health problem in the Western world. CRC is treatable with surgery and often curable when the disease is diagnosed at an…”
Get full text

Tumor Budding Versus Mismatch Repair Status in Colorectal Cancer - An Exploratory Analysis by Karlberg, Mia, Stenstedt, Kristina, Hallström, Marja, Ragnhammar, Peter, Lenander, Claes, Edler, David

“…Tumor budding and a proficient mismatch repair (pMMR) status are considered adverse prognostic factors in colorectal cancer (CRC). The aim of this pilot study…”
Get full text

Stroma-normalised vessel density predicts benefit from adjuvant fluorouracil-based chemotherapy in patients with stage II/III colon cancer by Mezheyeuski, Artur, Hrynchyk, Ina, Herrera, Mercedes, Karlberg, Mia, Osterman, Eric, Ragnhammar, Peter, Edler, David, Portyanko, Anna, Ponten, Fredrik, Sjöblom, Tobias, Glimelius, Bengt, Östman, Arne

“…Background Identification of biomarkers associated with benefit of adjuvant chemotherapy in stage II/III colon cancer is an important task. Methods Vessel…”
Get full text

Maintenance Therapy With Cetuximab Every Second Week in the First-Line Treatment of Metastatic Colorectal Cancer: The NORDIC-7.5 Study by the Nordic Colorectal Cancer Biomodulation Group by Pfeiffer, Per, Sorbye, Hafdan, Qvortrup, Camilla, Karlberg, Mia, Kersten, Christian, Vistisen, Kirsten, Lindh, Birgitta, Bjerregaard, Jon Kroll, Glimelius, Bengt

“…Micro-Abstract In the NORDIC-7.5 trial, cetuximab administered every 2 weeks in 152 patients with Kirsten rat sarcoma viral oncogene homolog wild type…”
Get full text

Persistent prevention of CIPN using calmangafodipir (PledOx): Results from a placebo-controlled randomized phase II study (PLIANT) in patients with metastatic colorectal cancer (mCRC) by Glimelius, Bengt, Manojlovic, Nebojsa, Pfeiffer, Per, Mosidze, Baadur, Kurteva, Galina Petrova, Karlberg, Mia, Mahalingam, Devalingam, Bengtson, Marie Helene, Nasstrom, Jacques

“…Abstract only…”
Get full text

The number of analyzed lymph nodes - a prognostic factor in colorectal cancer by Edler, David, Ohrling, Katarina, Hallström, Marja, Karlberg, Mia, Ragnhammar, Peter

“…The prognostic significance of the number of lymph nodes examined in surgical specimen of colorectal cancer was determined. One thousand and twenty five…”
Get more information

Maintenance therapy with biweekly cetuximab (C) in the first-line treatment of metastatic colorectal cancer (mCRC): The NORDIC 7.5 study (NCT00660582), by the Nordic Colorectal Cancer Biomodulation Group by Pfeiffer, Per, Sorbye, Halfdan, Qvortrup, Camilla, Karlberg, Mia, Naucler, Gisela, Kersten, Christian, Vistisen, Kirsten, Lindh, Birgitta, Glimelius, Bengt

“…Abstract only 3538 Background: NORDIC 7.5 is a multi-center phase II trial of Nordic FLOX plus biweekly C followed by maintenance C in first-line treatment of…”
Get full text

A Combined Analysis of Mismatch Repair Status and Thymidylate Synthase Expression in Stage II and III Colon Cancer by Öhrling, Katarina, Karlberg, Mia, Edler, David, Hallström, Marja, Ragnhammar, Peter

“…Micro-Abstract This study in 716 colon cancer patients evaluates if a combined instead of a single marker analysis of mismatch repair (MMR) status and…”
Get full text